<tfoot id="emo0q"><kbd id="emo0q"></kbd></tfoot>
<tfoot id="emo0q"><code id="emo0q"></code></tfoot>
  • <sup id="emo0q"><noscript id="emo0q"></noscript></sup>
  • <sup id="emo0q"></sup>
  • <tfoot id="emo0q"><code id="emo0q"></code></tfoot>
  • <sup id="emo0q"></sup><tfoot id="emo0q"></tfoot>
  • 您好,歡迎來到上海撫生實(shí)業(yè)有限公司!
    400-990-7709 / 021-52961052(工作日9:00-18:00)
    發(fā)布日期:2023/8/25 10:43:00

    期刊:Oxidative Medicine and Cellular Longevity


    文獻(xiàn)題目:Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy


    作者:Guo Lei-Ming, Ding Gao-Feng, Xu Wen-Cai, Ge Hong, Jiang Yue, Lu Yu-Fei


    DOI:10.1155/2022/5938688


    引用產(chǎn)品: hematoxylin


    影響因子:7.31


    原文鏈接:https://www.hindawi.com/journals/omcl/2022/5938688

    上一篇:JOURNAL OF CONTROLLED RELEASE 下一篇:Innovative Food Science & Emerging Technologies
    <tfoot id="emo0q"><kbd id="emo0q"></kbd></tfoot>
    <tfoot id="emo0q"><code id="emo0q"></code></tfoot>
  • <sup id="emo0q"><noscript id="emo0q"></noscript></sup>
  • <sup id="emo0q"></sup>
  • <tfoot id="emo0q"><code id="emo0q"></code></tfoot>
  • <sup id="emo0q"></sup><tfoot id="emo0q"></tfoot>